BNP Paribas Financial Markets’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.5K Buy
4,186
+1,668
+66% +$18.9K ﹤0.01% 3464
2025
Q1
$16.7K Sell
2,518
-1,904
-43% -$12.7K ﹤0.01% 3752
2024
Q4
$48.8K Sell
4,422
-71,732
-94% -$791K ﹤0.01% 3594
2024
Q3
$936K Buy
76,154
+71,647
+1,590% +$881K ﹤0.01% 1855
2024
Q2
$60.9K Sell
4,507
-9,823
-69% -$133K ﹤0.01% 2729
2024
Q1
$193K Buy
14,330
+6,636
+86% +$89.6K ﹤0.01% 2597
2023
Q4
$40.5K Sell
7,694
-20,458
-73% -$108K ﹤0.01% 2883
2023
Q3
$111K Buy
28,152
+20,847
+285% +$82.1K ﹤0.01% 2630
2023
Q2
$77.7K Sell
7,305
-3,475
-32% -$36.9K ﹤0.01% 2725
2023
Q1
$89.8K Sell
10,780
-20,784
-66% -$173K ﹤0.01% 2717
2022
Q4
$291K Buy
31,564
+14,452
+84% +$133K ﹤0.01% 2209
2022
Q3
$220K Buy
17,112
+2,736
+19% +$35.1K ﹤0.01% 2757
2022
Q2
$190K Buy
14,376
+12,731
+774% +$168K ﹤0.01% 2485
2022
Q1
$34.6K Sell
1,645
-2,426
-60% -$51.1K ﹤0.01% 3054
2021
Q4
$97.7K Sell
4,071
-12,131
-75% -$291K ﹤0.01% 2962
2021
Q3
$412K Buy
16,202
+15,492
+2,182% +$394K ﹤0.01% 2247
2021
Q2
$23.9K Sell
710
-3,477
-83% -$117K ﹤0.01% 2890
2021
Q1
$163K Buy
4,187
+2,235
+114% +$86.8K ﹤0.01% 2583
2020
Q4
$121K Sell
1,952
-944
-33% -$58.5K ﹤0.01% 2472
2020
Q3
$97K Buy
2,896
+2,181
+305% +$73K ﹤0.01% 2519
2020
Q2
$17K Sell
715
-4,505
-86% -$107K ﹤0.01% 2844
2020
Q1
$120K Buy
5,220
+3,958
+314% +$90.6K ﹤0.01% 2520
2019
Q4
$35.7K Buy
1,262
+104
+9% +$2.95K ﹤0.01% 3152
2019
Q3
$24.9K Buy
+1,158
New +$24.9K ﹤0.01% 3211